Features of Glucose Metabolism in Pleomorphic Hyalinizing Angiectatic Tumor (PHAT)

Po Jui Chang, Cher-Wei Liang, Ching Huei Kung, Ching Shui Huang, Chung-Huei Hsu

Research output: Contribution to journalArticle

Abstract

Pleomorphic Hyalinizing Angiectatic Tumor (PHAT) is a rare mesenchymal neoplasma. It is a pathological term describing a heterogeneous group of neoplasms of undetermined tumorigenesis and undefined malignancy. Based only on the morphological findings of histopathology, the biological potential of the tumor is indeterminate. Determination of glucose metabolism using FDG-PET revealed mildly increased FDG uptake in the tumor. We propose that FDG accumulation in the ectatic vessel, increased uptake of the pleomorphic cells and/or associated inflammatory cells, and increased permeability of the stroma lead to the imaging feature.
Original languageEnglish
Pages (from-to)11-13
Number of pages3
JournalAdvances in Molecular Imaging
Volume4
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint

Glucose
Neoplasms
Permeability
Carcinogenesis

Keywords

  • PHAT
  • FDG-PET
  • Sarcoma

Cite this

Features of Glucose Metabolism in Pleomorphic Hyalinizing Angiectatic Tumor (PHAT). / Chang, Po Jui; Liang, Cher-Wei; Kung, Ching Huei; Huang, Ching Shui; Hsu, Chung-Huei.

In: Advances in Molecular Imaging, Vol. 4, No. 1, 2014, p. 11-13.

Research output: Contribution to journalArticle

@article{9f417fdfb7b04e719efa5b45e862cb5e,
title = "Features of Glucose Metabolism in Pleomorphic Hyalinizing Angiectatic Tumor (PHAT)",
abstract = "Pleomorphic Hyalinizing Angiectatic Tumor (PHAT) is a rare mesenchymal neoplasma. It is a pathological term describing a heterogeneous group of neoplasms of undetermined tumorigenesis and undefined malignancy. Based only on the morphological findings of histopathology, the biological potential of the tumor is indeterminate. Determination of glucose metabolism using FDG-PET revealed mildly increased FDG uptake in the tumor. We propose that FDG accumulation in the ectatic vessel, increased uptake of the pleomorphic cells and/or associated inflammatory cells, and increased permeability of the stroma lead to the imaging feature.",
keywords = "PHAT, FDG-PET, Sarcoma, Sarcoma, FDG-PET, PHAT",
author = "Chang, {Po Jui} and Cher-Wei Liang and Kung, {Ching Huei} and Huang, {Ching Shui} and Chung-Huei Hsu",
year = "2014",
doi = "10.4236/ami.2014.41002",
language = "English",
volume = "4",
pages = "11--13",
journal = "Advances in Molecular Imaging",
issn = "2161-6728",
publisher = "Association for Scientific Research",
number = "1",

}

TY - JOUR

T1 - Features of Glucose Metabolism in Pleomorphic Hyalinizing Angiectatic Tumor (PHAT)

AU - Chang, Po Jui

AU - Liang, Cher-Wei

AU - Kung, Ching Huei

AU - Huang, Ching Shui

AU - Hsu, Chung-Huei

PY - 2014

Y1 - 2014

N2 - Pleomorphic Hyalinizing Angiectatic Tumor (PHAT) is a rare mesenchymal neoplasma. It is a pathological term describing a heterogeneous group of neoplasms of undetermined tumorigenesis and undefined malignancy. Based only on the morphological findings of histopathology, the biological potential of the tumor is indeterminate. Determination of glucose metabolism using FDG-PET revealed mildly increased FDG uptake in the tumor. We propose that FDG accumulation in the ectatic vessel, increased uptake of the pleomorphic cells and/or associated inflammatory cells, and increased permeability of the stroma lead to the imaging feature.

AB - Pleomorphic Hyalinizing Angiectatic Tumor (PHAT) is a rare mesenchymal neoplasma. It is a pathological term describing a heterogeneous group of neoplasms of undetermined tumorigenesis and undefined malignancy. Based only on the morphological findings of histopathology, the biological potential of the tumor is indeterminate. Determination of glucose metabolism using FDG-PET revealed mildly increased FDG uptake in the tumor. We propose that FDG accumulation in the ectatic vessel, increased uptake of the pleomorphic cells and/or associated inflammatory cells, and increased permeability of the stroma lead to the imaging feature.

KW - PHAT

KW - FDG-PET

KW - Sarcoma

KW - Sarcoma

KW - FDG-PET

KW - PHAT

U2 - 10.4236/ami.2014.41002

DO - 10.4236/ami.2014.41002

M3 - Article

VL - 4

SP - 11

EP - 13

JO - Advances in Molecular Imaging

JF - Advances in Molecular Imaging

SN - 2161-6728

IS - 1

ER -